Abbott Seeks to Terminate Alere Acquisition: 'Not The Company We Agreed To Buy'
December 07, 2016 at 11:49 AM EST
Abbott Laboratories (NYSE: ABT) has filed a complaint seeking to terminate its $5.8 billion proposed acquisition of Alere Inc (NYSE: ...